104 related articles for article (PubMed ID: 20150824)
1. Nocturnal blood pressure and progression to end-stage renal disease or death in nondiabetic chronic kidney disease stages 3 and 4.
Redon J; Plancha E; Swift PA; Pons S; Muñoz J; Martinez F
J Hypertens; 2010 Mar; 28(3):602-7. PubMed ID: 20150824
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of circadian blood pressure variation in chronic kidney disease.
Agarwal R; Kariyanna SS; Light RP
Am J Nephrol; 2009; 30(6):547-53. PubMed ID: 19844086
[TBL] [Abstract][Full Text] [Related]
3. Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis.
Wong CF; McCarthy M; Howse ML; Williams PS
Ren Fail; 2007; 29(6):653-9. PubMed ID: 17763158
[TBL] [Abstract][Full Text] [Related]
4. Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study.
Bakris GL; Weir MR; Shanifar S; Zhang Z; Douglas J; van Dijk DJ; Brenner BM;
Arch Intern Med; 2003 Jul; 163(13):1555-65. PubMed ID: 12860578
[TBL] [Abstract][Full Text] [Related]
5. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
[TBL] [Abstract][Full Text] [Related]
6. The rate of progression of renal disease may not be slower in women compared with men: a patient-level meta-analysis.
Jafar TH; Schmid CH; Stark PC; Toto R; Remuzzi G; Ruggenenti P; Marcantoni C; Becker G; Shahinfar S; De Jong PE; De Zeeuw D; Kamper AL; Strangaard S; Levey AS
Nephrol Dial Transplant; 2003 Oct; 18(10):2047-53. PubMed ID: 13679479
[TBL] [Abstract][Full Text] [Related]
7. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
Onuigbo MA; Onuigbo NT
QJM; 2008 Jul; 101(7):519-27. PubMed ID: 18375475
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of home blood pressure control on renal and cardiovascular outcomes in elderly patients with chronic kidney disease.
Okada T; Nakao T; Matsumoto H; Nagaoka Y; Tomaru R; Iwasawa H; Wada T
Hypertens Res; 2009 Dec; 32(12):1123-9. PubMed ID: 19816503
[TBL] [Abstract][Full Text] [Related]
9. Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial.
Ishani A; Grandits GA; Grimm RH; Svendsen KH; Collins AJ; Prineas RJ; Neaton JD
J Am Soc Nephrol; 2006 May; 17(5):1444-52. PubMed ID: 16611715
[TBL] [Abstract][Full Text] [Related]
10. Treatment of hypertension in chronic kidney disease.
Toto RD
Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
[TBL] [Abstract][Full Text] [Related]
11. Utility of 24-h ambulatory blood pressure measurement in a routine clinical setting of patients with chronic renal disease.
Jacob P; Hartung R; Bohlender J; Stein G
J Hum Hypertens; 2004 Oct; 18(10):745-51. PubMed ID: 15103314
[TBL] [Abstract][Full Text] [Related]
12. Primary glomerulonephritis: an update on renal survival and determinants of progression.
Moranne O; Watier L; Rossert J; Stengel B;
QJM; 2008 Mar; 101(3):215-24. PubMed ID: 18245806
[TBL] [Abstract][Full Text] [Related]
13. Ambulatory blood pressure monitoring in the prediction of cardiovascular events and effects of chronotherapy: rationale and design of the MAPEC study.
Hermida RC
Chronobiol Int; 2007; 24(4):749-75. PubMed ID: 17701685
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of stage 3-5 chronic kidney disease before end-stage renal disease at a single center in Taiwan.
Chiu YL; Chien KL; Lin SL; Chen YM; Tsai TJ; Wu KD
Nephron Clin Pract; 2008; 109(3):c109-18. PubMed ID: 18663322
[TBL] [Abstract][Full Text] [Related]
15. Lower progression rate of end-stage renal disease in patients with peripheral arterial disease using statins or Angiotensin-converting enzyme inhibitors.
Feringa HH; Karagiannis SE; Chonchol M; Vidakovic R; Noordzij PG; Elhendy A; van Domburg RT; Welten G; Schouten O; Bax JJ; Berl T; Poldermans D
J Am Soc Nephrol; 2007 Jun; 18(6):1872-9. PubMed ID: 17475817
[TBL] [Abstract][Full Text] [Related]
16. "Non-dipper" hypertensive patients and progressive renal insufficiency: a 3-year longitudinal study.
Timio M; Venanzi S; Lolli S; Lippi G; Verdura C; Monarca C; Guerrini E
Clin Nephrol; 1995 Jun; 43(6):382-7. PubMed ID: 7554522
[TBL] [Abstract][Full Text] [Related]
17. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort.
Levin A; Djurdjev O; Beaulieu M; Er L
Am J Kidney Dis; 2008 Oct; 52(4):661-71. PubMed ID: 18805347
[TBL] [Abstract][Full Text] [Related]
18. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial.
Minutolo R; Gabbai FB; Borrelli S; Scigliano R; Trucillo P; Baldanza D; Laurino S; Mascia S; Conte G; De Nicola L
Am J Kidney Dis; 2007 Dec; 50(6):908-17. PubMed ID: 18037091
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal observations on circadian blood pressure variation in chronic kidney disease stages 3-5.
Elung-Jensen T; Strandgaard S; Kamper AL
Nephrol Dial Transplant; 2008 Sep; 23(9):2873-8. PubMed ID: 18353888
[TBL] [Abstract][Full Text] [Related]
20. Effect of dietary protein restriction on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study.
Levey AS; Greene T; Sarnak MJ; Wang X; Beck GJ; Kusek JW; Collins AJ; Kopple JD
Am J Kidney Dis; 2006 Dec; 48(6):879-88. PubMed ID: 17162142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
